Rodion Amirov Diagnosed With Brain Tumor

The Toronto Maple Leafs released a shocking and heartbreaking message to fans today. Rodion Amirov, the team’s first-round draft pick from 2020, has been diagnosed with a brain tumor. The young forward is receiving medical attention at a facility in Germany after extensive testing the last few months led to this discovery. General manager Kyle Dubas explained:

Rodion commenced the 2021-22 season with Salavat Ufa of the KHL but suffered an injury to open the season. During the course of his recovery from this injury, he developed some new, unrelated symptoms that required ongoing extensive investigations over the last few months.

Rodion is currently undergoing treatment at a medical facility in Germany and will not return to play for the remainder of the season.

Our medical staff has been involved throughout the process alongside Ufa’s and we are in direct contact with the facility on an ongoing basis to monitor his treatment and care. Rodion has the complete support of the Toronto Maple Leafs organization and we will continue to ensure he receives the best care possible throughout this process.

Out of respect for Rodion and his family, the Club will not have any further comment at this time.

Amirov, 20, has played just ten games this season with Ufa Salavat Yulayev, his KHL team. Speaking with Sportsnet, Amirov explained that he wants to “stay positive” and for people to “think positively” about him.

The young forward will not play again this season as he continues treatment, though his agent released a statement that includes some encouraging news. Amirov is still skating three times a week and working out every day. He is in “good spirits” and is “determined to return back to professional hockey.”